TY - JOUR
T1 - Frontal Lobe Function in Progressive Supranuclear Palsy
AU - Grafman, Jordan
AU - Litvan, Irene
AU - Gomez, Claudia
AU - Chase, Thomas N.
PY - 1990/5
Y1 - 1990/5
N2 - Performance on tasks evaluating “executive and attentional” processes presumably subserved by prefrontal cortex were compared in patients with progressive supranuclear palsy and with age and education-matched control subjects. The results indicated that patients with progressive supranuclear palsy were particularly impaired when a task required sequential movements, conceptual shifting, monitoring the frequency with which stimuli are presented, or rapid retrieval of verbal knowledge. These deficits could not simply be accounted for by slowed information processing or by a deficit in representational knowledge. Conceivably, “weak activation” of frontal lobe representational knowledge characterized by an observed attentional deficit results in the neuropsychological impairments noted in patients with progressive supranuclear palsy. The oral administration of physostigmine, under double-blind placebo-controlled conditions, did not facilitate executive or attentional performance as evaluated by our tasks.
AB - Performance on tasks evaluating “executive and attentional” processes presumably subserved by prefrontal cortex were compared in patients with progressive supranuclear palsy and with age and education-matched control subjects. The results indicated that patients with progressive supranuclear palsy were particularly impaired when a task required sequential movements, conceptual shifting, monitoring the frequency with which stimuli are presented, or rapid retrieval of verbal knowledge. These deficits could not simply be accounted for by slowed information processing or by a deficit in representational knowledge. Conceivably, “weak activation” of frontal lobe representational knowledge characterized by an observed attentional deficit results in the neuropsychological impairments noted in patients with progressive supranuclear palsy. The oral administration of physostigmine, under double-blind placebo-controlled conditions, did not facilitate executive or attentional performance as evaluated by our tasks.
UR - http://www.scopus.com/inward/record.url?scp=0025234589&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0025234589&partnerID=8YFLogxK
U2 - 10.1001/archneur.1990.00530050077015
DO - 10.1001/archneur.1990.00530050077015
M3 - Article
C2 - 2334303
AN - SCOPUS:0025234589
SN - 0003-9942
VL - 47
SP - 553
EP - 558
JO - Archives of Neurology
JF - Archives of Neurology
IS - 5
ER -